C49 COPD: TREATMENT: Effect Of Roflumilast On Exacerbations In Patients With Severe COPD And A History Of Hospitalization Receiving Inhaled Combination Therapy: A Pooled Analysis Of Two Randomized Phase 4 Studies

Introduction: Roflumilast is a selective phosphodiesterase-4 inhibitor that reduces the risk of exacerbations in severe COPD patients with chronic bronchitis and an exacerbation history. Conclusions: Both REACT and RE SPOND identified a specific COPD patient phenotype, with a history of >1 COPD-r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser:	Martinez, F J, Rabe, K F, Calverley, P, Fabbri, L M, Sethi, S, Pizzichini, E, McIvor, A, Anzueto, A, Alagappan, V, Saddiqui, S, Reisner, C, Zetterstrand, S, Roman, J, Bagul, N, Rennard, S I
Format:	Artikel
Sprache:	eng
Schlagworte:	Bronchitis Chronic obstructive pulmonary disease Combination therapy Hospitalization Patients Population
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!